Abstract
Randomized Phase II Study of All-Trans Retinoic Acid and Valproic Acid Added to Decitabine in Newly Diagnosed Elderly AML Patients (DECIDER trial): Predictive Impact of TP53 Status
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have